Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SUMO2 | P61956 | 1/20 | 0.44 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP3 | Q9H4L4 | 1/20 | 0.44 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.44 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL343357 | 0.74 | MYC (0.44) | SUMO2SUMO1SENP7SENP3SENP2 | |
| SCHEMBL3056943 | 0.74 | CA1 (0.44) | SENP7MAPTALDH1A1SMN1; SMN2SIGMAR1 | |
| O-Xylene SCHEMBL29725142 | 0.73 | TSHR (0.62) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| O-Xylene SCHEMBL6155104 | 0.73 | TSHR (0.62) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| O-Xylene SCHEMBL28085642 | 0.73 | TSHR (0.62) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL3045674 | 0.71 | ALDH1A1 (0.50) | MAPTALDH1A1SMN1; SMN2TSHRMEN1 | |
| SCHEMBL2915678 | 0.71 | CYP1A2 (0.46) | CYP2C9ALDH1A1SIGMAR1TSHRGRIN2D | |
| SCHEMBL153241 | 0.71 | CYP1A2 (0.46) | CYP2C9ALDH1A1SIGMAR1TSHRGRIN2D | |
| O-Xylene SCHEMBL6364677 | 0.71 | TSHR (0.59) | MAPTALDH1A1SMN1; SMN2NPC1RAB9A | |
| O-Xylene SCHEMBL10476945 | 0.71 | TSHR (0.59) | ALDH1A1SMN1; SMN2NPC1RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100221502-A1 | Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-09-02 | — | — | US | claimed |
| US-7223301-B2 | Anthrapyridone compound, water-based magenta ink composition and inkjet recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-05-29 | — | — | US | claimed |
| US-20060219131-A1 | Anthrapyridone compound, aqueous magenta ink composition and inkjet recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-10-05 | — | — | US | claimed |
| EP-1626069-A1 | ANTHRAPYRIDONE COMPOUND, AQUEOUS MAGENTA INK COMPOSITION AND INKJET RECORDING METHOD | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-02-15 | — | — | EP | claimed |
| US-20100221502-A1 | Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-09-02 | — | — | US | disclosed |
| US-7223301-B2 | Anthrapyridone compound, water-based magenta ink composition and inkjet recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-05-29 | — | — | US | disclosed |
| US-20060219131-A1 | Anthrapyridone compound, aqueous magenta ink composition and inkjet recording method | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1626069-A1 | ANTHRAPYRIDONE COMPOUND, AQUEOUS MAGENTA INK COMPOSITION AND INKJET RECORDING METHOD | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-02-15 | — | — | EP | disclosed |
| EP-0085378-B1 | COPPER COMPLEX DISAZO COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-03-19 | — | — | EP | disclosed |
| EP-0085378-A2 | Copper complex disazo compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-08-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100221502-A1 | Anthrapyridone Compound and Salt Thereof, Magenta Ink Composition Containing the Anthrapyridone Compound, and Colored Article | ABL1, ATXN2L, ANXA7 | SUMO2 3287/4885SUMO1 3324/4885SENP7 3727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.